Answers are grounded in this paper and cite their sources.
Aims Further decompensation events markedly increase mortality in patients with decompensated cirrhosis. The coagulation factor VIII/protein C (FVIII/PC) ratio, previously considered as an indicator of thromboembolic events, has recently been recognized as an important prognostic factor in cirrhosis. This study aimed to identify risk factors for predicting further decompensation and to evaluate the predictive value of the FVIII/PC ratio in patients with decompensated cirrhosis. Methods A total of 227 patients were enrolled between January 2020 and December 2021, and followed until June 30, 2023, or until the occurrence of further decompensation. Fine‐Gray competing risk models and the Shapley additive explanations method were used to identify significant predictors of 1‐year further decompensation. The predictive performance of the FVIII/PC ratio was assessed using time‐dependent receiver operating characteristic curves (ROC) and Kaplan–Meier analysis. Results During follow‐up, 62 patients (27.3%) experienced further decompensating events. A high FVIII/PC ratio and an elevated model for end‐stage liver disease score were identified as independent risk factors for further decompensation. The FVIII/PC ratio showed superior predictive performance within 1 year, with an area under the curve of 0.717. Patients were categorized into low ( n = 126) and high FVIII/PC ( n = 101) groups using the optimal cutoff value (2.86) derived from time‐dependent ROC analysis. Kaplan–Meier analysis demonstrated that patients with a high FVIII/PC ratio had a significantly greater risk of further decompensation (high vs. low FVIII/PC groups: 16.2% vs. 3.3%, p = 0.001), including variceal hemorrhage (high vs. low FVIII/PC groups: 8.9% vs. 1.7%, p = 0.017), jaundice (high vs. low FVIII/PC groups: 8.0% vs. 1.7%, p = 0.031), and recurrent ascites (high vs. low FVIII/PC groups: 16.2% vs. 4.8%, p = 0.010). In contrast, neither the FVIII/PC ratio (high vs. low FVIII/PC groups: 10.7% vs. 9.2%, p = 0.670) nor PC levels (high vs. low PC groups in those without portal vein thrombosis (PVT) at baseline: 7.1% vs. 14.0%, p = 0.200) predicted PVT, while FVIII levels alone remained significant (high vs. low FVIII groups in those without PVT at baseline: 17.9% vs. 6.1%, p = 0.029). Conclusion An increased FVIII/PC ratio is a key predictor of higher risk for further decompensation in patients with decompensated cirrhosis. The activity of FVIII, rather than the FVIII/PC ratio, is recommended for evaluating and predicting the occurrence of PVT.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: